Drawing for DIVERSYS SUPERANTIBODIES

USPTO serial 76312447

DIVERSYS SUPERANTIBODIES

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
SNAPP, TINA LOUISE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DIVERSYS SUPERANTIBODIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Diane Donnelly

DIANE DONNELLY VON MALTITZ, DERENBERG, KUNIN, ET AL60 E 42ND STNEW YORK, NY 10165-0006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICALS, ANTIBODIES, ANTIBODY LIBRARIES, PHAGE ANTIBODIES; PHARMACEUTICAL PREPARATIONS AND SUBSTANCESACTIVE—
042ANTIBODY DESIGN AND SELECTION,ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 3, 2002ABN1ABANDONMENT - EXPRESS MAILED—
Mar 14, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 1, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2002DOCKASSIGNED TO EXAMINER—
Dec 21, 2001DOCKASSIGNED TO EXAMINER—
Oct 26, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2001AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—

Frequently asked questions

Related guidance